Shandong Pharmaceutical Glass Co., Ltd. (600529) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Pharmaceutical Glass Co., Ltd.

Why is Shandong Pharmaceutical Glass Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 15.33%

The company has been able to generate a Return on Capital Employed (avg) of 15.33% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 4.49% and Operating profit at 2.17% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 11.15% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 4.49% and Operating profit at 2.17% over the last 5 years

The company has declared Negative results for the last 5 consecutive quarters

INTEREST(HY) At CNY 0.71 MM has Grown at 6,230.26%
OPERATING CASH FLOW(Y) Lowest at CNY 413.87 MM
ROCE(HY) Lowest at 8.25%

With ROE of 7.89%, it has a attractive valuation with a 1.42 Price to Book Value

Over the past year, while the stock has generated a return of -13.77%, its profits have fallen by -28.7%
At the current price, the company has a high dividend yield of 4.4

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Pharmaceutical Glass Co., Ltd. should be less than 10%
Overall Portfolio exposure to Packaging should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Packaging)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Pharmaceutical Glass Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Pharmaceutical Glass Co., Ltd.

-13.47%

-1.32

21.11%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.49%

EBIT Growth (5y)

2.17%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

465.75

Tax Ratio

16.93%

Dividend Payout Ratio

44.26%

Pledged Shares

Institutional Holding

ROCE (avg)

14.26%

ROE (avg)

11.15%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.42

EV to EBIT

12.76

EV to EBITDA

11.25

EV to Capital Employed

1.57

EV to Sales

2.17

PEG Ratio

Dividend Yield

4.35%

ROCE (Latest)

12.31%

ROE (Latest)

7.89%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

OPERATING PROFIT MARGIN(Q)

Highest at 28.57 %

-17What is not working for the Company

INTEREST(HY)

At CNY 0.71 MM has Grown at 6,230.26%

OPERATING CASH FLOW(Y)

Lowest at CNY 413.87 MM

ROCE(HY)

Lowest at 8.25%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.86 times

RAW MATERIAL COST(Y)

Grown by 11.62% (YoY

NET SALES(Q)

Lowest at CNY 1,061.33 MM

Here's what is working for Shandong Pharmaceutical Glass Co., Ltd.

Operating Profit Margin

Highest at 28.57 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Here's what is not working for Shandong Pharmaceutical Glass Co., Ltd.

Interest

At CNY 0.71 MM has Grown at 6,230.26%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 413.87 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Lowest at 1.86 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

Lowest at CNY 1,061.33 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Raw Material Cost

Grown by 11.62% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales